Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Appelbaum F. R., Fisher L. D., Thomas E. D. Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up. Blood. 1988 Jul;72(1):179–184. [PubMed] [Google Scholar]
- Berenson R. J., Bensinger W. I., Hill R. S., Andrews R. G., Garcia-Lopez J., Kalamasz D. F., Still B. J., Spitzer G., Buckner C. D., Bernstein I. D. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood. 1991 Apr 15;77(8):1717–1722. [PubMed] [Google Scholar]
- Champlin R. E., Ho W. G., Gale R. P., Winston D., Selch M., Mitsuyasu R., Lenarsky C., Elashoff R., Zighelboim J., Feig S. A. Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy. Ann Intern Med. 1985 Mar;102(3):285–291. doi: 10.7326/0003-4819-102-3-285. [DOI] [PubMed] [Google Scholar]
- Dunbar C. E., Stewart F. M. Separating the wheat from the chaff: selection of benign hematopoietic cells in chronic myeloid leukemia. Blood. 1992 Mar 1;79(5):1107–1110. [PubMed] [Google Scholar]
- Kernan N. A., Bartsch G., Ash R. C., Beatty P. G., Champlin R., Filipovich A., Gajewski J., Hansen J. A., Henslee-Downey J., McCullough J. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med. 1993 Mar 4;328(9):593–602. doi: 10.1056/NEJM199303043280901. [DOI] [PubMed] [Google Scholar]
- Linch D. C., Winfield D., Goldstone A. H., Moir D., Hancock B., McMillan A., Chopra R., Milligan D., Hudson G. V. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet. 1993 Apr 24;341(8852):1051–1054. doi: 10.1016/0140-6736(93)92411-l. [DOI] [PubMed] [Google Scholar]
- Löwenberg B., Verdonck L. J., Dekker A. W., Willemze R., Zwaan F. E., de Planque M., Abels J., Sonneveld P., van der Lelie J., Goudsmit R. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study. J Clin Oncol. 1990 Feb;8(2):287–294. doi: 10.1200/JCO.1990.8.2.287. [DOI] [PubMed] [Google Scholar]
- Mandelli F., Avvisati G., Amadori S., Boccadoro M., Gernone A., Lauta V. M., Marmont F., Petrucci M. T., Tribalto M., Vegna M. L. Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy. N Engl J Med. 1990 May 17;322(20):1430–1434. doi: 10.1056/NEJM199005173222005. [DOI] [PubMed] [Google Scholar]
- Osterborg A., Björkholm M., Björeman M., Brenning G., Carlson K., Celsing F., Gahrton G., Grimfors G., Gyllenhammar H., Hast R. Natural interferon-alpha in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III: a randomized study from the Myeloma Group of Central Sweden. Blood. 1993 Mar 15;81(6):1428–1434. [PubMed] [Google Scholar]
- Zander A. R., Keating M., Dicke K., Dixon D., Pierce S., Jagannath S., Peters L., Horwitz L., Cockerill K., Spitzer G. A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission. J Clin Oncol. 1988 Oct;6(10):1548–1557. doi: 10.1200/JCO.1988.6.10.1548. [DOI] [PubMed] [Google Scholar]
- Zittoun R., Mandelli F., De Witte T., Willemze R., Tura S. Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocol. Bone Marrow Transplant. 1990 Jul;6 (Suppl 1):56–58. [PubMed] [Google Scholar]